(Q40341858)

English

Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

carbapenem antibiotic

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

Senol S

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tasbakan M

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pullukcu H

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sipahi OR

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sipahi H

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yamazhan T

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Arda B

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ulusoy S

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

355-357

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Economics of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

A Multicenter Comparative Study of Meropenem and Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections in Hospitalized Patients

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2010.22.5.355

21 January 2018

Identifiers

10.1179/JOC.2010.22.5.355

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40341858&oldid=1895748448"